Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

James River Coal Company Coal (JRCC), CSX Corporation (CSX), Norfolk Southern Corp. (NSC): This Coal Miner Owns the Wrong Coal

Page 1 of 2

James River Coal Company Coal (NASDAQ:JRCC)’s main operations are in the Central Appalachian coal basin (CAPP). That’s a region that’s experiencing a downward trend in demand. Although the company has tried to diversify into new coal markets, it’s probably not enough to fight this long-term shift.

The wrong coal

In its second-quarter conference call, the CEO of rail company CSX Corporation (NYSE:CSX) noted that in 2010, “about 12% of our coal originations on CSX were coming out of the Illinois Basin and this most recent quarter about 28%. And most of that coal has displaced Central Appalachian coal, which is down fairly significantly.”

CSX Corporation (CSX)

That’s a big shift and one that clearly has an impact on CSX Corporation (NYSE:CSX). The company earns more from carrying Illinois Basin coal (ILB) to customers that have switched away from CAPP coal because of the greater distance ILB coal has to travel on its lines. Even better, the company expects originations of ILB coal to go “a lot higher…”

Fellow train hauler Norfolk Southern Corp. (NYSE:NSC) recently highlighted a similar hauling shift on its train line. Of all the coal basins the company serves, the ILB is effectively the only one that has seen increased shipments since 2010, nearly doubling from 8% to 15% of second quarter shipments.

The biggest laggard was CAPP coal, falling five percentage points. That said, CAPP coal still makes up over one-third of the company’s business and requires a much longer haul than ILB coal at Norfolk Southern Corp. (NYSE:NSC). That suggests that this ongoing shift won’t be as kind to Norfolk Southern Corp. (NYSE:NSC)’s business as it will be to CSX Corporation (NYSE:CSX)’s.

Benefiting from the switch

This coal-basin shift is a trend that’s buffeted Alliance Resource Partners, L.P. (NASDAQ:ARLP), since ILB coal accounted for about 75% of its tons sold in the second quarter. Such basin-switching has allowed Alliance to increase production at the very time that others are pulling back. For example, in the second quarter, the partnership increased the tons it sold by more than 13%.

The ILB is the bedrock on which the company’s growth is pinned:  “The strong performance of our Illinois Basin operations through the first half of 2013 is expected to continue over the balance of the year.” And Alliance Resource Partners, L.P. (NASDAQ:ARLP) expects 2013 to be its “13th consecutive year of record results.”

The wrong focus

That’s not the case at James River Coal Company Coal (NASDAQ:JRCC). Central Appalachian coal accounts for around 80% of the company’s coal volume. With customers shifting their buying to the ILB, James River has seen its sales stall.

The company shipped nearly 25% less coal in the first six months of the year than it did in the same period last year. The drop in demand for CAPP coal accounted for all of that decline, since the company actually increased the tons sold out of its much smaller Midwest segment, which operates in the ILB.

This is why the company was forced to idle all production for a week and has switched its Kentucky operations to a four-day work week. James River Coal Company Coal (NASDAQ:JRCC) has a big problem on its hands. This problem appears to have worsened as the company announced on Monday that it would idle three more Kentucky mines and place around 525 on furlough. That’s roughly 25% of JRCC’s workforce.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!